Prevalence and prognosis of chronic fibrosing interstitial lung diseases with a progressive phenotype.

Reoto TakeiKevin K BrownYasuhiko YamanoKensuke KataokaToshiki YokoyamaToshiaki MatsudaTomoki KimuraAtsushi SuzukiTaiki FurukawaJunya FukuokaTakeshi JohkohYoshihito GotoYasuhiro Kondoh

Published in: Respirology (Carlton, Vic.) (2022)

Over one-fourth of non-IPF FILD patients develop a progressive phenotype compared to approximately 60% of IPF patients. The survival of non-IPF FILD patients with a progressive phenotype is similar to IPF.

Keyphrases

idiopathic pulmonary fibrosis
end stage renal disease
multiple sclerosis
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
patient reported outcomes
risk factors
patient reported